SCAI 2020 Scientific Sessions
Format:495 videos + 531 pdfs, size: 40.5 GB
Course Audience: cardiologist, angiography and interventions physician
1. SafeFemoral
2. ACHD Starts Young
3. Acute and Chronic Thromboembolic Pulmonary Disease
4. Advocacy 101
5. Advocacy in Interventional Cardiology Joseph Babb Memorial Symposium
6. Algorithms for Challenging Cath Lab Scenarios A Case-Based Approach
7. Aorto-Illiac Disease Case-Based Approach
8. Best Cases at SCAI 2020
9. Best Complex Structural Cases
10. Best Coronary Complications Cases
11. The Best of Catheterization and Cardiovascular Interventions 2019
12. The Best of Circulation Cardiovascular Interventions 2019
13. Best of JACC Cardiovascular Interventions
14. Best of Quality Tip-of-the-Month
15. Best Peripheral Complications Cases
16. Cardiogenic Shock
17. Cardiovascular Professionals Symposium Antithrombotic Pharmacology
18. Cardiovascular Professionals Symposium Growing a Structural Heart Program
19. Cardiovascular Professionals Symposium Hemodynamics and SHOCK
20. Case-Based Approach to SFA (Superficial Femoral Artery)
21. Cases Over Cocktails
22. Cath Conference Case-Based Discussion
23. CHD Community Forum
24. CHD Late Breaking Science
25. Chronic Total Occlusion (CTO) Current Approaches
26. MD, MSCAI Presidential Inauguration and Member Induction, FSCAI & MSCAI Recognition
27. Complication Management
28. Congenital Heart Disease Cases
29. Controversy! Transcatheter Aortic Valve Replacement
30. Conversations with Masters
31. COVID-19 and Mechanical Circulatory Support
32. COVID-19 Session Perspectives From the Front Lines of the Pandemic
33. Critical Limb Ischemia (CLI)
34. Cutting-Edge Medical Therapy for Peripheral Vascular Disease
35. Emerging Technologies in the Peripheral Space
36. Essential Skills for the Structuralist
37. Featured Clinical Research
38. Fundamentals of PFO Therapy
39. Harnessing the Power of Social Media
40. A Healthy and Diverse Cath Lab Charles Chambers Memorial Symposium
41. High-Risk and Complex PCI
42. How the Guidelines Apply to Real Life Case Based
43. Hypercoagulability and Antithrombotic Recommendations During the COVID-19 Pandemic
44. Imaging When and How And What Am I Looking At
45. Interventional Cardio-Oncology
46. Interventional Life, Part I How To
47. Interventional Life, Part II Getting Things Done
48. Intravenous Platelet Inhibition in PCI Case-Based Look at Expanding Applications
49. Keys for a Successful Left Atrial Appendage Program
50. LDL Management for the Interventionalist
51. Learning From the Past
52. Left Atrial Occlusion and PFO Closure – Clinical Update
53. Left Main Strategies
54. Left Main Strategies
55. Lessons from the ISCHEMIA Trial
56. The Low-Risk TAVR Patient Considerations in 2020
57. Management of Calcified Lesions Atherectomy and Intravascular Lithotripsy (IVL)
58. Management of Complex Coronary Lesions-Optimizing cPCI in a Dynamic Environment
59. Management of the cPCI Patient CTO, Bifurcations, and High Bleeding Risk
60. Mullin’s Lecture
61. The New Frontier of Transcatheter Tricuspid Interventions
62. Oh My Goodness Pulmonary Vein Stenosis
63. Oh My! Obstruction and Rupture
64. Oops! How to Stay Out of Trouble A Primer on Complications
65. Oral Abstracts – Focus on the Patent Arterial Duct
66. Other Stuff That Does Not Go Well
67. Paravalvular Regurgitation Plug the Hole!
68. PCI Management of Complex Anatomic Subsets
69. Peripheral Vascular Interventions How the Guidelines Apply to Real Life
70. Peripheral Vascular Interventions State Of the Art
71. Physiology-Guided PCI
72. Planning Complicated Interventions and Dealing With Unpredictable Complications
73. Polyvascular Disease, Secondary Prevention in PVI Patients With PVD
74. Programmatic and Technological Innovations in the Cath Lab
75. Protocol-Based Care and Opportunities for Standardization
76. Psychology of the Interventional Cardiologist
77. Quality The Good, the Bad, and the Ugly
78. Robotic PCI
79. SCAI Clinical Documents
80. SCAI Complex Peripheral Vascular Interventions (SCAI-CPVI) Summit Interactive Case Discussions
81. SCAI Town Hall with Q&A
82. SCAI TRAnsition for VALUE Incorporating Prior Bypass Patients Into Your TRA cPCI Practice
83. SCAI Women in Innovations (SCAI-WIN) Symposium Cases in Structural Heart Disease
84. SCAI Women in Innovations (SCAI-WIN) Symposium Structural Heart Intervention
85. SCAI Women in Innovations (SCAI-WIN) Coronary Artery Disease and Interventions
86. SCAI ACC Joint Session Cath Lab Economics
87. SCAI Cardiovascular Research Foundation (CRF) Joint Session PCI State of the Art
88. Structural Heart Program Building and Management
89. TAVR in the COVID-19 Era and Beyond
90. Transcatheter Mitral Repair Simplifying Expanded Indications
91. Transcatheter Mitral Replacement Today and Tomorrow
92. Transcatheter Mitral Replacement Today and Tomorrow
93. Transcatheter Mitral Valve Repair and Replacement Selection, Therapy, and Outcomes
94. TRIP Radial Access and Beyond
95. The Tsunami of TAVR Translating the Science Into Practice for All Patients
96. Welcome by 2020 Scientific Sessions Program
97. What the Imager Can and Should Tell the Proceduralist
ePosters
Highlights